In the lymphoid cell compartment of patients with early MS, using antibody Panel A, we detected increased frequencies of CD4+ and CD8+ cells that highly expressed CCR7 and were negative for CD95 (Fas). This evidence concerns the gene FAS and myeloid sarcoma.